The roles of parafibromin expression in ovarian epithelial carcinomas: a marker for differentiation and prognosis and a target for gene therapy

The clinicopathological significances and biological functions of parafibromin expression in head and neck squamous cell carcinomas

(2015) Zhuo Zhang et al.   TUMOR BIOLOGY

Parafibromin, Galectin-3, PGP9.5, Ki67, and Cyclin D1: Using an Immunohistochemical Panel to Aid in the Diagnosis of Parathyroid Cancer

(2014) Peter P. Truran et al.   WORLD JOURNAL OF SURGERY

Cytoplasmic parafibromin/hCdc73 targets and destabilizes p53 mRNA to control p53-mediated apoptosis

(2014) Jay-Hyun Jo et al.   Nature Communications

Effects of Parafibromin Expression on the Phenotypes and Relevant Mechanisms in the DLD-1 Colon Carcinoma Cell Line

(2013) Shuang Zhao et al.   Asian Pacific Journal of Cancer Prevention

Transcriptional Repression of Tumor SuppressorCDC73, Encoding an RNA Polymerase II Interactor, by Wilms Tumor 1 Protein (WT1) Promotes Cell Proliferation

(2013) Mohammad Iqbal Rather et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

CDC73 mutational status and loss of parafibromin in the outcome of parathyroid cancer

(2013) Filomena Cetani et al.   Endocrine Connections

Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological features

(2012) Jaime Prat   VIRCHOWS ARCHIV

Caffeine induces apoptosis by enhancement of autophagy via PI3K/Akt/mTOR/p70S6K inhibition

(2011) Shinji Saiki et al.   Autophagy

The tumor suppressor CDC73 interacts with the ring finger proteins RNF20 and RNF40 and is required for the maintenance of histone 2B monoubiquitination

(2011) Michael A. Hahn et al.   HUMAN MOLECULAR GENETICS

Parafibromin expression is an independent prognostic factor for colorectal carcinomas

(2011) Hua-chuan Zheng et al.   HUMAN PATHOLOGY

Downregulation of CASR expression and global loss of parafibromin staining are strong negative determinants of prognosis in parathyroid carcinoma

(2011) Janneke E Witteveen et al.   MODERN PATHOLOGY

SHP2 Tyrosine Phosphatase Converts Parafibromin/Cdc73 from a Tumor Suppressor to an Oncogenic Driver

(2011) Atsushi Takahashi et al.   MOLECULAR CELL

H2S Protects Hippocampal Neurons from Anoxia–Reoxygenation Through cAMP-Mediated PI3K/Akt/p70S6K Cell-Survival Signaling Pathways

(2010) Jian-Lin Shao et al.   JOURNAL OF MOLECULAR NEUROSCIENCE

Cell/tissue-tropic functions of Wnt5a signaling in normal and cancer cells

(2010) Michiru Nishita et al.   TRENDS IN CELL BIOLOGY

SV40 T antigen disrupted the cell metabolism and the balance between proliferation and apoptosis in lens tumors of transgenic mice

(2009) Hua-chuan Zheng et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Parafibromin - functional insights

(2009) P. J. Newey et al.   JOURNAL OF INTERNAL MEDICINE

The tumor suppressor, parafibromin, mediates histone H3 K9 methylation for cyclin D1 repression

(2009) Yong-Jin Yang et al.   NUCLEIC ACIDS RESEARCH

The parafibromin tumor suppressor protein interacts with actin-binding proteins actinin-2 and actinin-3

(2008) Sunita K Agarwal et al.   Molecular Cancer

The parafibromin tumor suppressor protein inhibits cell proliferation by repression of the c-myc proto-oncogene

(2008) L. Lin et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA